About the Company
We do not have any company description for NKGen Biotech, Inc. at the moment.
Exchange
OTC
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on NKGen Biotech, Inc.
NKGen Biotech, Inc. to Become Publicly Traded Company via ... - Nasdaq
--NKGen Biotech, Inc., a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK Natural Killer cell therapeutics, and ...
NKGen Biotech, Inc. Reports Third Quarter 2023 Financial ... - Nasdaq
--NKGen Biotech Inc., a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic, and CAR-NK natural killer cell therapeutics ...
NKGen Biotech, Inc. Announces Closing of Business Combination
Company to Commence Trading on Nasdaq under Ticker Symbol “NKGN” on Monday, October 2, 2023SANTA ANA, Calif., Oct. 02, 2023 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (“NKGen” or the ...
NKGen Biotech, Inc. Announces First Patient Dosed in Phase I Clinical ...
SANTA ANA, Calif., Aug. 24, 2023 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization ...
NKGen Biotech, Inc. to Transition from the Nasdaq Global Market to OTC ...
NKGen Biotech, Inc. (“NKGen” or the “Company”) has regained compliance on its public reporting obligations with the filing of its most recent quarterly report on Form 10-Q on March 4, 2025 ...
NKGen Biotech, Inc.: NKGen Biotech Announces New Funding to Regain ...
SANTA ANA, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) ("NKGen" or the "Company"), a clinical-stage biotechnology company focused on the development and ...
NKGen Biotech Inc. Wt (NKGNW) Stock Price Today - WSJ
View the latest NKGen Biotech Inc. Wt (NKGNW) stock price, news, historical charts, analyst ratings and financial information from WSJ.
NKGN - NKGen Biotech Inc Dividends | Morningstar
Review the current NKGen Biotech Inc (NKGN:PINX) dividend yield and history to decide if NKGN is the best investment for you.
NKGen Biotech Stock Short Interest Report | OTC:NKGN | Benzinga
Short interest in NKGen Biotech Inc (OTC:NKGN) decreased during the last reporting period, falling from 243.03K to 82.76K. This put 0.3% of the company's publicly available shares short.
NKGen Biotech, Inc. Reports Third Quarter 2023 Financial Results and ...
SANTA ANA, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- NKGen Biotech Inc. (Nasdaq: NKGN) (NKGen or the Company), a clinical-stage biotechnology company focused on the development and ...
Similar Companies
Loading the latest forecasts...